top of page
Search

eCTD v4.0 Gap Analysis + Document Prep: How ECTD Pharma Helps You Avoid Costly Rejections


ree


2026 Is Coming — And Most Teams Are Guessing

January 1, 2026: FDA requires eCTD v4.0. One bad PDF. One broken link. One missing bookmark.Technical rejection.Weeks of rework.Delayed approval.

We’ve seen it:


80% of 2025 pilot issues were document-related. (FDA ESG Validation Trends, Q3 2025)

At ECTD Pharma, we’ve completed 12+ v4.0 gap analyses and document prep projects in 2025. Result: No client has had a technical rejection after our review.

Not magic. Just thorough, practical, human-reviewed work.

Our Service: Gap Analysis + Document Preparation

What We Do

What You Get

Time

Gap Analysis

Full audit of your v3.2.2 → v4.0 gaps

5–7 days

Document Prep

PDF fixes, bookmarks, hyperlinks, metadata

3–5 days

Total Package

Submission-ready module

8–10 business days

Fixed Price: $6,900 (covers one full module or up to 50 docs)


How It Works — Step by Step


1. Gap Analysis

We review every file against FDA v4.0 rules:

  • Broken links?

  • Missing study tags?

  • Non-compliant PDFs?


You get:


  • Clear report (PDF + Excel)

  • Prioritized fixes with out strict traffic light system

  • Risk level (low/medium/high)


2. Document Preparation


We fix what’s broken:

Task

Why It Matters

How We Do It

PDF Compliance

Must be PDF/A-3b

Convert + validate

Bookmarks

FDA expects hierarchy

Auto-build + QA

Hyperlinks

Must work in v4.0

Rebuild with stable URIs

Metadata

Required for lifecycle

Add study tags, keywords

Searchable Text

No scanned images

OCR + verify

You get:

  • Clean, clickable PDFs

  • Validation-ready files

  • ESG test report (we run a mock)


Real Example: What We Fixed for a Client


Client: Small US biotech (IND resubmission) Problem:


  • 38 PDFs

  • 112 validation warnings

  • Broken hyperlinks, missing bookmarks

Our Fix (9 days):

  1. Gap report → 112 issues mapped

  2. Rebuilt all PDFs + hyperlinks

  3. Ran mock v4.0 submission in ESG

Result:


ESG passed with 3 minor warnings (fixed same day). Client: “Saved us from a 3-week delay.”

7 Common Issues We Fix

Issue

Risk

Our Fix

Scanned PDFs

Not searchable

OCR + retype if needed

Flat bookmarks

Hard to navigate

Full hierarchy

Dead hyperlinks

Validation fail

Rebuild with URIs

Wrong PDF version

Auto-reject

Convert to PDF/A-3b

Duplicate files

Confusion

Dedupe + link

Missing tags

Lifecycle error

Add XML metadata

Font issues

Display errors

Embed all fonts

Free Document Health Check (5 Minutes)


Ask yourself:


  1. Are your PDFs PDF/A-3b?

  2. Do all sections have bookmarks?

  3. Are hyperlinks clickable in a new folder?

  4. Is all text searchable?

  5. Have you tested in ESG?


Not sure? We’ll check one PDF for free!


Why Work With ECTD Pharma?

You Want

We Deliver

Speed

8–10 days

Clarity

Simple reports, no jargon

Price

£49 per document

Support

Around the clock support with lead consultants

Tools

Freyr, Acrobat Pro


No upsells. No surprises.

 
 
 

Comments


EMEA
MHRA
FDA
swissmedic
Health CA

Regulatory Submission Services | eCTD Publishing Experts – eCTD Pharma
At eCTD Pharma, we deliver industry-leading regulatory submission services tailored for the pharmaceutical, biotech, and healthcare sectors. Our expertise in eCTD publishing, regulatory gap analysis, and legacy submission conversions ensures your submissions are 100% compliant with EMA, FDA, and global health authority standards. Using advanced Freyr software, we provide fast, accurate, and secure electronic submissions, reducing approval timelines and minimizing compliance risks. Whether you need end-to-end eCTD submission support, lifecycle management, or expert consultancy, eCTD Pharma is your trusted partner. Maximize compliance. Minimize delays. Accelerate approvals. Contact eCTD Pharma today to streamline your regulatory process.

bottom of page